drugset / Trial / NCT02831283

Imaging Inflammation in Alzheimer's Disease

NCT02831283

Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

This study is being done to learn about inflammation and amyloid in Alzheimer's disease. A type of brain scan called a PET scan is used measure 1) inflammation and 2) abnormal accumulation of a the amount of a certain protein fragment called beta-amyloid (plaques) in the brain. These are thought to be involved in Alzheimer's disease. The investigators will also perform brain MRI and do tests to measure the participants' memory and thinking.

Timeline

Start
2016-06
Primary completion
2022-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 11C-PBR28 Diagnostic / imaging agent 740 mbq
Subject 18F-Florbetaben Diagnostic / imaging agent 299.7 mbq

Indications